July 2012 SKIN SURGERY SERVICE BRIEFING NOTES

Similar documents
Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

SKIN SERVICES REVIEW Changes to Medicare Benefits Schedule for 1 November 2016

Faster Cancer Treatment Indicators: Use cases

Activity Report March 2013 February 2014

(SCARD) At any time to clarify any issues you can contact us by on

Hauora Maori. Map. Non-Melanoma Skin Lesion. Clinically Seborrhoeic Keratosis. Management Options. Punch Biopsy. Refer to Public Skin Lesion Service

Department of Dermatology, Queen Margaret & Victoria Hospitals

Nonmelanoma skin cancers

OCCG SERVICE SPECIFICATION (2017/18)

Skin cancer excision performance in Scottish primary and secondary care:

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

BCC follow up audit. South West Public Health Observatory

Dermatology GP Referral Guidelines

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

Malignant Melanoma Care Pathway

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Accuracy of Clinical Skin Tumour Diagnosis in a Dermatological Setting.

Minor surgery. Introduction

Periocular Malignancies

Skin Cancer of the Nose: Common and Uncommon

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Clinical characteristics

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

PLASTICS Referral Guidelines

Plastic Surgery Referral Guidelines

Patients who smoke should be encouraged to stop smoking at least 8 weeks before surgery to reduce the risk of surgery and the risk of complications.

RCGP and Cancer Research UK Workshop. Hilton Newcastle Gateshead, Bottle Bank, Gateshead, NE8 2AR 13 th July 2017

Alcohol should be avoided for 3 days prior to surgery and 2 days after the procedure.

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

The Plastic Surgery See and Treat Skin Cancer Clinic (SATSKIN)

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

SKIN LESIONS. On behalf of Airedale, Wharfedale and Craven CCG, Bradford City CCG and Bradford Districts CCG. Bradford and Airedale CCGs.

Section 1. Lids and lacrimal COPYRIGHTED MATERIAL

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee

World Journal of Colorectal Surgery

Cuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015

Corporate Medical Policy

Developed by Marion Wood and Children s Dental Needs Steering Group

COSMETIC PROCEDURES ANNUAL REPORT 2014/15

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Research Scholarships for PhD Students

Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1

Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs Lung /chest wall sarcomas incl. pulmonary metastatectomy Version 2

JAM ACAD DERMATOL VOLUME 76, NUMBER 2. Research Letters 351

Dermatology pilots. Ram Patel GPwSI Dermatology Gateway lead for Dermatology.

PanMidlands Ocular Cancer Pathway March 2008 Approved by The Midland Oculoplastic Surgery Society

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

A Cross-Sectional Survey of a Dermatology Outpatient Service in Malta

Skin Cancer A Personal Approach. Dr Matthew Strack Dunedin New Zealand

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Skin lesions suspicious for melanoma: New Zealand excision margin guidelines in practice

Service Specification: CPO Skin Lesions

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Periocular skin cancer

Attending Physician Statement- Cancer or Carcinoma in-situ

DataDerm Quality Measures

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

MOHS MICROGRAPHIC SURGERY

Dermatology Procedure Coding

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

Moh's Surgery Information Packet

Dr Stephen Hayes Associate Specialist in Dermatology University Hospital Southampton

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

Clinical Practice Guide. Basal cell carcinoma, squamous cell carcinoma (and related lesions) a guide to clinical management in Australia

Specialised Services Commissioning Policy: CP34 Circumcision for children

Melanoma. Consultation on draft guideline - stakeholder comments. Comments to be submitted before 5pm on Friday 13 March 2015

Single Suspected Cancer Pathway Definitions pathway start date

Northern Ireland Bowel Cancer Screening Programme. Pathways. Version 4 1 st October 2013

Interesting Case Series. Aggressive Tumor of the Midface

Basal cell carcinoma 5/28/2011

Diagnostics Assessment Programme

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use

Soft Tissue Tumour & Sarcoma Imaging Guidelines 2012

Schedule of Benefits for General Practitioners

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry

Larry Tan, MD Thoracic Surgery, HSC. Community Cancer Care Educational Conference October 27, 2017

SQUAMOUS CELL CARCINOMA OF THE SKIN IN A TROPICAL SETTING

Epithelial Cancer- NMSC & Melanoma

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

Mole mapping and monitoring. Dr Stephen Hayes. Associate Specialist in Dermatology, University Hospital Southampton

Diagnostics guidance Published: 11 November 2015 nice.org.uk/guidance/dg19

NHS: 2002 PCA(O)6 abcdefghijklm

Article XIX DENTAL HYGIENIST COLLABORATIVE CARE PROGRAM

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Squamous Cell Carcinoma. Basal Cell Carcinoma. Regional Follow-up Guidelines

Apps and Telemedicine H. Peter Soyer Dermatology Research Centre

Annual Report Skin MDT

Primary Health Networks

Expected Non Melanoma Skin (Keratinocytic) Cancer incidence in New Zealand for 2018

Stephen C. Joseph, M.D., M.P.H.

CANCER INSIGHT. FOR GPs. Summer 2018 WHAT YOU NEED TO KNOW ABOUT SKIN CANCER VISIT. our Skin Cancer Recognition Toolkit at

Data & Definitions Frequently Asked Questions

abcdefghijklmnopqrstu

Medical gap arrangements - practitioner application

Referral of Patients. to the. Community Dental Referral Service. Hillingdon

Appendix C NEWBORN HEARING SCREENING PROJECT

Monash Health Referral Guidelines

Transcription:

SKIN SURGERY SERVICE BRIEFING NOTES

Introduction The WBoP PHO has an agreement with the BoP District Health Board to deliver the Skin Surgery Service. The current period will expire on 30 June 2012 and the new period will be 01 July 30 June 2014. Eligible Patients An eligible patient: a) Has one of the identified skin lesions; b) Is referred by a General Practitioner; and c) Resides in one of the following locations: - Tauranga District - Western Bay of Plenty District - Mayor or Motiti Island Previously it was a person enrolled in a Bay of Plenty Primary Health Organisation. Entitled Lesions Lesions entitled under the service are: Pigmented when histology indicates the following types: Melanoma Melanoma in situ Dysplastic naevus Other pigmented cutaneous malignancy Non-Pigmented when biopsy testing indicates the following types: Basal cell carcinoma Squamous cell carcinoma including in situ Other non-pigmented cutaneous malignancies including keratoacanthoma Suspicion Lesions Excision of any suspicious pigmented or non-pigmented lesions not of a type set out under exclusions below: Exclusions The following lesions are NOT entitled under the Skin Surgery Service: Sebhorrhoeic Keratoses Lipomas Sebaceous cysts Warts Solar Keratoses All other non-malignant lesion not listed above Referral Pathway All referrals for skin cancer lesions must be made to the Skin Surgery Service and not the Tauranga Referral Centre. Referrals will be delayed as they will be sent back to the referring GP if they are sent to the Tauranga without being referred to the Skin Surgery Service.

Punch Biopsies / Full Skin Assessment Patients pay for their own Punch Biopsy and Full Skin Assessment. Two variations to this rule apply: 1. Where a doctor seeks a second opinion, they may refer the patient to the Skin Surgery Service who will arrange a GPSI to provide that opinion. The Skin Surgery Service shall pay for the second opinion. 2. Where a doctor does not feel competent to assess the patient they may refer the patient to the Skin Surgery Service who will arrange for an assessment to occur. The patient will be expected to pay for any Punch Biopsy or Full Skin Assessment arising from this assessment. All Lesions Require Approval All lesions require Skin Surgery Service approval if funding is to be assigned. Approval is lesion by lesion. Any surgery undertaken without approval will not be funded. Three Lesions per Day Each patient may receive surgery up to a maximum of three approved lesions per day. GPSIs are encouraged to undertake up to this limit each day, where it is clinically appropriate to do so. Phasing surgery over a longer period without clear clinical grounds was an issue under the previous agreement. Referral Process This is now electronic using Best Practice. It is important that this process is fully understood. While five referral pathways exist, Pathway 1 (see diagram) will be the most commonly utilised. Processing Referrals The Skin Surgery Service has engaged an independent clinician to assist in the processing of referrals. At the end of each month, referrals shall be considered and scored against the Surgical Priority Schedule and the General Scoring Criteria. Lesions will be placed in descending order of priority. Funds will be assigned going down the schedule until the funds are fully assigned. Where a referral is of particular clinical urgency, consideration may occur more immediately. This will be an exception to the rule however. The referrer will need to justify this in the Clinical Lesion Notes section of the electronic referral form. Invoicing / Histology Reports An invoice should be forwarded at the completion of the surgical process. It should be submitted to the Skin Surgery Service by the 10 th of the following month. This allows for timely payment and better financial management. All invoices shall include GST. Histology Reports It should be noted that payment shall not occur until histology reports have been received on all relevant lesions.

Pathway 1 Pathway 2 WBoP PHO Skin Surgery Referral Process Practice Initiates Electronic Form Patient is assessed and pays for assessment (PBx and FSA). Practice may refer to the Skin Surgery Service by completing the electronic referral form. Second Opinion A GP may seek a second opinion through the Skin Surgery Service by details on the Electronic Referral Form to the Skin Surgery Service that referral is required for a second opinion only. The Skin Surgery Service receives referral and prepares for triage by an Independent Clinician at the end of the month. Grading will result in one of three options. Not for Triage Skin Surgery Service refers on to a GPSI for a second opinion. This is not an approval for surgery at this point. Approved lesions Assigned to correctly credentialed GPSI Surgery to occur (ASAP) i.e. < 20 working days Declined lesions Referring GP notified within 5 working days lesions All relevant documentation forwarded and GP notified within 5 working days Assigned GPSI advises initiating GP of that opinion and forwards a copy to the Skin Surgery Service. Pathway 3 Pathway 4 Not competent to assess skin lesions Any GP may refer to the Skin Surgery Service where a GP is unable to refer a patient directly to another GP for assessment. They may seek to do so through the Skin Surgery Service. GPs are encouraged to refer within their own practice or elsewhere prior to referring to the Skin Surgery Service. Non-Urgent Lesions Where a GPSI finds a lesion other than the one approved for surgery. Skin Surgery Service receives referral and assigns GPSI to undertake first assessment. Patient pays. Advise the Skin Surgery Service and referring GP in a discharge letter back to patient s own GP. Assigned GPSI advises Skin Surgery Service and referring GP of outcome. A referral may result. A referral may result Pathway 5 Urgent Lesions Where a credentialed GPSI finds an urgent or another concerning lesion other than the one referred for surgery. Advise the Skin Surgery Service. An urgent request is fast- tracked for triage and referred appropriately for surgery. Appropriate notification for approval, hospital level, or decline Other Re-excision (wider ellipse) and Staged procedure requests. (Flaps, skin grafts, staged excisions) All re-excisions are required to be referred to triage for grade of surgery prior to surgery taking place. Approval for re-excision on a melanoma site will take priority. Predicted staged procedures require notification to the Skin Surgery Service in referral via Pathway 1. If this has not been done in the first referral, approval is required for any subsequent surgery in a second referral.

Surgical Priority Schedule As referred to in previous section Skin Surgery Service 30 July 2009 Surgical Priority Schedule Cancer Histology Suspected Melanoma MMI, MMR, MMV 100 Rare Malignant Tumours OPM or ONPM 100 High Risk Invasive SCCs SCCO 100 Keratoacanthoma KA 100 Lower Risk Invasive SCCs Head/Neck Aggressive BCC (micronodular, sclerosed, infiltrating) Head/Neck SCCO 100 BCCO 100 SCC in situ and BCC Head/Neck SCCI, BCCN, BCCS 60 Lower risk SCC and aggressive BCC Trunk/Limbs Nodular BCC Trunk and limbs > 10mm Hands and feet > 5mm All other BCCs Trunk/Limbs SCC insitu Trunk/Limbs SCCO, BCCN 60 BCCN 60 BCCO, BCCN, BCCS 40 SCCI 40

General Scoring Criteria As referred to in previous section It is important that referrers place brief notes where information relevant to the General Scoring Criteria may be pertinent. Please place these in the Clinical Lesion Notes box please. General Scoring Criteria Life Threatening Likely to Progress to Major Complication 40 Likely to Continue to Deteriorate 20 Likely to Remain Stable 10 Likely Potential to Benefit High 30 Moderate 10 Low 0 Social Participation / Independence Intermediately Threatened 30 Not Threatened but Difficult 10 Post Assessment Once the assessment and placing of lesions in descending order of priority has occurred, the referring doctor, and assigned GPSI shall be notified (refer Skin Surgery Service Referral Processes Flow Diagram). Where a lesion has been approved for surgery, the referring doctor and assigned GPSI surgeon will be notified. The relevant documentation shall be forwarded to the GPSI. Where a lesion has not been approved for surgery, the referring doctor and patient shall be notified within five (5) working days of the assessment. The notification shall indicate the assigned score as well as the score at which the funds expired that month. Re-Excisions and Incompletes All Re-excisions and Incompletes are required to be referred to the Skin Surgery Service by GPSIs. In most cases, surgery will be approved immediately.

Grading Lesions by Location and Size The following parameters shall apply. Please note changes do exist from the previous contract. These arise as the method of measurement changes from size of ellipse to lesion diameter. The changed method of measurement means GPSIs undertaking BASIC surgery will have a slightly larger range of surgical activity. An adjustment in fees has been made to account for this. Skin Surgery Service 30 July 2009 Grading of Lesions by Location and Size Anatomical Location Lesion Size (diameter) Head and Neck Intermediate Plus < 5 mm 6 to 10 mm > 11 to 15mm > 16mm T Zone Plus < 4 mm 5 to 8 mm > 9mm Below the Knee Intermediate Plus < 5 mm 6 to 10 mm 11 to 15 mm > 16mm Elsewhere Basic Intermediate Plus < 5 mm 6 to 10 mm 11 to 15 mm >16 to 20mm > 21mm